Prazosin treatment of primary Raynaud's phenomenon
Tóm tắt
In a double blind study, prazosin, a specific adrenergic alpha1-receptor antagonist, or placebo were given to 15 females with primary Raynaud's phenomenon. At a low dose (1 mg twice daily) 5 out of 7 of the prazosin-treated patients reported a reduction of attacks induced by cold (p<0.05). This was not confirmed by a cold provocation test which showed no improvement at finger temperatures of 15 or 10°C. The highest tolerated dose in the prazosin-treated patients varied from 2–8 mg daily, and the greatest number of side effects was recorded in this group (p<0.05). None of the patients experienced complete relief from cold-induced attacks. It was concluded either that Raynaud's phenomenon is not only caused by stimulation of alpha1-receptors in digital arteries, or the clinically achievable blockade was insufficient to prevent attacks.
Tài liệu tham khảo
Lewis T, Pickering GW (1934) Observations upon maladies in which the blood supply to the digits ceases intermittently or permanently, and upon bilateral gangrene of digits. Observations relevant to so-called Raynaud's disease. Clin Sci 1: 327–366
Nielsen SL (1978) Raynaud's phenomena and finger systolic pressure during cooling. Scand J Clin Lab Invest 36: 731–737
Coffmann JD (1979) Vasodilator drugs in peripheral vascular disease. N Engl J Med 300: 713–717
Nobin BA, Nielsen SL, Ekløv B, Lassen NA (1978) Reserpine treatment of Raynaud's disease. Ann Surg 187: 12–16
Nielsen SL, Christensen NJ, Olsen N, Lassen NA (1980) Raynaud's phenomenon: Peripheral catecholamine concentration and effect of sympatectomy. Acta Chir Scand 502: 57–62
Appleby BR (1978) Raynaud's phenomenon? Med J Austr 2: 437–438
Cobaugh DS (1980) Prazosin treatment of ergotamine-induced peripheral ischemia. J Am Med Assoc 244: 1360
Waldo R (1979) Prazosin relieves Raynaud's vasospasm. J Am Med Assoc 214: 1037
Brogden RN, Heel RC, Speight TM, Avery GS (1977) Prazosin: A review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs 14: 163–197
Coffmann JD, Davies WT (1975) Vasospastic diseases: A review. Prog Cardiovasc Dis 18: 123–146
Vanhoutte PM, Janssens WJ (1980) Thermosensitivity of cutaneous vessels and Raynaud's disease. Am Heart J 100: 263–265
Jauernig RA, Moulds RFW, Shaw J (1978) The action of prazosin in human vascular preparations. Arch Int Pharmacodyn 231: 81–89
Pedersen OL, Mikkelsen E, Andersson K-E (1979) Comparison of the in vitro effects of prazosin, nifedipine and dihydralazine in isolated human mesenteric and crural vessels. Arch Int Pharmacol 241: 224–234
Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic α-adrenoreceptors in vascular smooth muscle in vivo. Br J Pharmacol 67: 207–215